Hemodynamic and clinical effects of a new inotropic agent TA-064 in patients with refractory heart failure due to cardiomyopathy with special reference to dose-response effects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples